BURGALASSI, SUSI Statistiche
BURGALASSI, SUSI
DIPARTIMENTO DI FARMACIA
A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition
2024-01-01 Malakoti-Nejad, Maryam; Monti, Daniela; Burgalassi, Susi; Bardania, Hassan; Elahi, Elahe; Morshedi, Dina
How to evaluate if microorganisms isolated from sterile drug production environments monitoring are undesirable
2024-01-01 Ceccanti, Stefano; Vecchiani, Sandra; Leonangeli, Giulia; Burgalassi, Susi; Federigi, Ileana; Carducci, Annalaura; Verani, Marco
Nanomicellar eye drops: a review of recent advances
2024-01-01 Paganini, Valentina; Chetoni, Patrizia; Di Gangi, Mariacristina; Monti, Daniela; Tampucci, Silvia; Burgalassi, Susi
Binary Polymeric Surfactant Mixtures for the Development of Novel Loteprednol Etabonate Nanomicellar Eyedrops
2023-01-01 Tampucci, S.; Monti, D.; Burgalassi, S.; Terreni, E.; Paganini, V.; Di Gangi, M.; Chetoni, P.
Ciclopirox Hydroxypropyl Chitosan (CPX‐HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application
2022-01-01 Monti, Daniela; Tampucci, Silvia; Paganini, Valentina; Burgalassi, Susi; Chetoni, Patrizia; Galván, Jordi; Celandroni, Francesco; Ghelardi, Emilia
Functionalized Hyaluronic Acid for “In Situ” Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome
2022-01-01 Burgalassi, Susi; Fragai, Marco; Francesconi, Oscar; Cerofolini, Linda; Monti, Daniela; Leone, Gemma; Lamponi, Stefania; Greco, Giuseppe; Magnani, Agnese; Nativi, Cristina
Hydrogels as Corneal Stroma Substitutes for In Vitro Evaluation of Drug Ocular Permeation
2022-01-01 Burgalassi, S; Zucchetti, E; Ling, L; Chetoni, P; Tampucci, S; Monti, D
MAGL inhibitor NanoMicellar formulation (MAGL-NanoMicellar) for the development of an antiglaucoma eye drop
2022-01-01 Chetoni, Patrizia; Burgalassi, Susi; Zucchetti, Erica; Granchi, Carlotta; Minutolo, Filippo; Tampucci, Silvia; Monti, Daniela
Nanostructured Drug Delivery Systems for Targeting 5-alpha-Reductase Inhibitors to the Hair Follicle
2022-01-01 Tampucci, Silvia; Paganini, Valentina; Burgalassi, Susi; Chetoni, Patrizia; Monti, Daniela
Sporopollenin Microcapsule: Sunscreen Delivery System with Photoprotective Properties
2022-01-01 Tampucci, Silvia; Tofani, Giorgio; Chetoni, Patrizia; Di Gangi, Mariacristina; Mezzetta, Andrea; Paganini, Valentina; Burgalassi, Susi; Pomelli, Christian Silvio; Monti, Daniela
A hybrid ocular delivery system of cyclosporine-A comprising nanomicelle-laden polymeric inserts with improved efficacy and tolerability
2021-01-01 Terreni, E.; Chetoni, P.; Burgalassi, S.; Tampucci, S.; Zucchetti, E.; Chipala, E.; Alany, R. G.; Al-Kinani, A. A.; Monti, D.
Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system (Odds) for cyclosporine-a
2021-01-01 Terreni, E.; Zucchetti, E.; Tampucci, S.; Burgalassi, S.; Monti, D.; Chetoni, P.
Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy
2021-01-01 Radwan, S. E. -S.; El-Kamel, A.; Zaki, E. I.; Burgalassi, S.; Zucchetti, E.; El-Moslemany, R. M.
Objectionable microorganisms in pharmaceutical production: validation of a decision tree
2021-01-01 Burgalassi, Susi; Ceccanti, Stefano; Vecchiani, Sandra; Leonangeli, Giulia; Federigi, Ileana; Carducci, Annalaura; Verani, Marco
Ocular application of oleuropein in dry eye treatment: Formulation studies and biological evaluation
2021-01-01 Burgalassi, S.; Zucchetti, E.; Birindelli, E.; Tampucci, S.; Chetoni, P.; Monti, D.
Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-nano) for ocular delivery of cyclosporine-A
2020-01-01 Terreni, E.; Chetoni, P.; Tampucci, S.; Burgalassi, S.; Al-Kinani, A. A.; Alany, R. G.; Monti, D.
Bimatoprost 0.01% solution compositions for the treatment of ocular hypertension
2020-01-01 Chetoni, Patrizia; Burgalassi, Susi; Monti, Daniela; Tampucci, Silvia; Falcone, Giulia; Matsigkou, Christina
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert
2020-01-01 Terreni, E; Burgalassi, S.; Chetoni, P.; Tampucci, S.; Zucchetti, E.; Fais, R.; Ghelardi, E.; Lupetti, A.; Monti, D.
Formulations based on natural ingredients for treatment of nail diseases
2020-01-01 Tampucci, Silvia; Zucchetti, Erica; Burgalassi, Susi; Chetoni, Patrizia; Monti, Daniela; Terreni, Eleonora.
pH-responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy
2020-01-01 Tampucci, S.; Guazzelli, L.; Burgalassi, S.; Carpi, S.; Chetoni, P.; Mezzetta, A.; Nieri, P.; Polini, B.; Pomelli, C. S.; Terreni, E.; Monti, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition | 1-gen-2024 | Malakoti-Nejad, Maryam; Monti, Daniela; Burgalassi, Susi; Bardania, Hassan; Elahi, Elahe; Morshedi, Dina | |
| How to evaluate if microorganisms isolated from sterile drug production environments monitoring are undesirable | 1-gen-2024 | Ceccanti, Stefano; Vecchiani, Sandra; Leonangeli, Giulia; Burgalassi, Susi; Federigi, Ileana; Carducci, Annalaura; Verani, Marco | |
| Nanomicellar eye drops: a review of recent advances | 1-gen-2024 | Paganini, Valentina; Chetoni, Patrizia; Di Gangi, Mariacristina; Monti, Daniela; Tampucci, Silvia; Burgalassi, Susi | |
| Binary Polymeric Surfactant Mixtures for the Development of Novel Loteprednol Etabonate Nanomicellar Eyedrops | 1-gen-2023 | Tampucci, S.; Monti, D.; Burgalassi, S.; Terreni, E.; Paganini, V.; Di Gangi, M.; Chetoni, P. | |
| Ciclopirox Hydroxypropyl Chitosan (CPX‐HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application | 1-gen-2022 | Monti, Daniela; Tampucci, Silvia; Paganini, Valentina; Burgalassi, Susi; Chetoni, Patrizia; Galván, Jordi; Celandroni, Francesco; Ghelardi, Emilia | |
| Functionalized Hyaluronic Acid for “In Situ” Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome | 1-gen-2022 | Burgalassi, Susi; Fragai, Marco; Francesconi, Oscar; Cerofolini, Linda; Monti, Daniela; Leone, Gemma; Lamponi, Stefania; Greco, Giuseppe; Magnani, Agnese; Nativi, Cristina | |
| Hydrogels as Corneal Stroma Substitutes for In Vitro Evaluation of Drug Ocular Permeation | 1-gen-2022 | Burgalassi, S; Zucchetti, E; Ling, L; Chetoni, P; Tampucci, S; Monti, D | |
| MAGL inhibitor NanoMicellar formulation (MAGL-NanoMicellar) for the development of an antiglaucoma eye drop | 1-gen-2022 | Chetoni, Patrizia; Burgalassi, Susi; Zucchetti, Erica; Granchi, Carlotta; Minutolo, Filippo; Tampucci, Silvia; Monti, Daniela | |
| Nanostructured Drug Delivery Systems for Targeting 5-alpha-Reductase Inhibitors to the Hair Follicle | 1-gen-2022 | Tampucci, Silvia; Paganini, Valentina; Burgalassi, Susi; Chetoni, Patrizia; Monti, Daniela | |
| Sporopollenin Microcapsule: Sunscreen Delivery System with Photoprotective Properties | 1-gen-2022 | Tampucci, Silvia; Tofani, Giorgio; Chetoni, Patrizia; Di Gangi, Mariacristina; Mezzetta, Andrea; Paganini, Valentina; Burgalassi, Susi; Pomelli, Christian Silvio; Monti, Daniela | |
| A hybrid ocular delivery system of cyclosporine-A comprising nanomicelle-laden polymeric inserts with improved efficacy and tolerability | 1-gen-2021 | Terreni, E.; Chetoni, P.; Burgalassi, S.; Tampucci, S.; Zucchetti, E.; Chipala, E.; Alany, R. G.; Al-Kinani, A. A.; Monti, D. | |
| Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system (Odds) for cyclosporine-a | 1-gen-2021 | Terreni, E.; Zucchetti, E.; Tampucci, S.; Burgalassi, S.; Monti, D.; Chetoni, P. | |
| Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy | 1-gen-2021 | Radwan, S. E. -S.; El-Kamel, A.; Zaki, E. I.; Burgalassi, S.; Zucchetti, E.; El-Moslemany, R. M. | |
| Objectionable microorganisms in pharmaceutical production: validation of a decision tree | 1-gen-2021 | Burgalassi, Susi; Ceccanti, Stefano; Vecchiani, Sandra; Leonangeli, Giulia; Federigi, Ileana; Carducci, Annalaura; Verani, Marco | |
| Ocular application of oleuropein in dry eye treatment: Formulation studies and biological evaluation | 1-gen-2021 | Burgalassi, S.; Zucchetti, E.; Birindelli, E.; Tampucci, S.; Chetoni, P.; Monti, D. | |
| Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-nano) for ocular delivery of cyclosporine-A | 1-gen-2020 | Terreni, E.; Chetoni, P.; Tampucci, S.; Burgalassi, S.; Al-Kinani, A. A.; Alany, R. G.; Monti, D. | |
| Bimatoprost 0.01% solution compositions for the treatment of ocular hypertension | 1-gen-2020 | Chetoni, Patrizia; Burgalassi, Susi; Monti, Daniela; Tampucci, Silvia; Falcone, Giulia; Matsigkou, Christina | |
| Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert | 1-gen-2020 | Terreni, E; Burgalassi, S.; Chetoni, P.; Tampucci, S.; Zucchetti, E.; Fais, R.; Ghelardi, E.; Lupetti, A.; Monti, D. | |
| Formulations based on natural ingredients for treatment of nail diseases | 1-gen-2020 | Tampucci, Silvia; Zucchetti, Erica; Burgalassi, Susi; Chetoni, Patrizia; Monti, Daniela; Terreni, Eleonora. | |
| pH-responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy | 1-gen-2020 | Tampucci, S.; Guazzelli, L.; Burgalassi, S.; Carpi, S.; Chetoni, P.; Mezzetta, A.; Nieri, P.; Polini, B.; Pomelli, C. S.; Terreni, E.; Monti, D. |